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ABSTRACT
Objectives: The aim of this study is a head-to-head compari-
son of the performance of the three-level EQ-5D (3L) and a
newly developed ﬁve-level version (5L).
Methods: Eighty-two respondents valued 15 standardized
disease descriptions and their own health on three response
scales (3L, 5L, and visual analog scale [VAS]) for all ﬁve
EQ-5D dimensions. Performance was studied in terms of
feasibility, face validity, redistribution properties, ordinality,
convergent validity, discriminatory power, and test–retest
and interobserver reliability.
Results: The majority of participants judged 5L as the
preferred system in terms of feasibility (76%) and face vali-
dity (75%). In total, 1.1% of responses were inconsistent.
Ordinality of 5L was conﬁrmed in all cases. Convergent
validity of 3L-VAS (range: 0.88–0.99) and 5L-VAS (0.90–
0.99) were high and about equal. Discriminatory power
(informativity) improves considerably with 5L without loss
of Evenness. Interobserver reliability (0.49 vs. 0.57) and test–
retest reliability (0.52 vs. 0.69) were higher in 5L.
Conclusion: The EQ-5D ﬁve-level version appears a valid
and reliable extension of the three-level system. The new 5L
system is particularly useful for describing mild health prob-
lems and monitoring population health.
Keywords: EQ-5D, health status, health-related quality-of-
life, methodology, psychometrics.
Introduction
The EQ-5D is a widely used instrument to measure
and value generic health (status). The EQ-5D descrip-
tive system describes generic health in terms of ﬁve
dimensions: Mobility, Self-Care, Usual Activities, Pain/
Discomfort, and Anxiety/Depression. Each dimension
deﬁnes three levels, indicating no problems, some or
moderate problems and extreme problems, resulting in
a total of 243 (= 35) unique health states (permuta-
tions). Besides descriptive purposes, the EQ-5D can
also be used to assign preference values to the
described health states [1].
The condensed format of EQ-5D undoubtedly con-
tributed to its global dissemination, but compared
with other generic preference-based instruments such
as the Health Utilities Index Mark 2 and Mark 3
(HUI2 and HUI3) and the Short Form 6D (SF-6D),
that deﬁne respectively 24,000, 972,000, and 18,000
unique health states, EQ-5D is lacking descriptive rich-
ness, at least at the theoretical level [2–5]. The EQ-5D
was originally designed to complement other instru-
ments but is now increasingly used as a “stand alone”
measure. For a preference-based measure, extra levels
are precious, because the descriptive system becomes
increasingly complex, and the derivation of a robust
set of preference weights more challenging, which
partly explains its condensed format. Despite its
brevity, EQ-5D in general performs exceptionally well
when compared to more comprehensive instruments.
Nevertheless, its restricted ability to discriminate small
to moderate differences in health status between indi-
viduals or within individuals over time is recognized
[6–9]. Moreover, several studies reported on the ceiling
effect of the EQ-5D, in general population as well as
patient population settings [10–15]. A simple way of
improving the discriminatory potential of the EQ-5D
descriptive system is by increasing the number of
response options (levels).
This article presents a head-to-head comparison of
the standard three-level EQ-5D descriptive system (3L)
with a newly developed ﬁve-level version (5L) which
covers 3125 unique health states (= 55). We investi-
gated redistribution properties of the 5L extension of
EQ-5D, i.e., how do responses to a similar disease
condition on the standard 3L EQ-5D redistribute in a
5L system? Ordinality of the new 5L system is inves-
tigated by assessing transitivity between 5L scores,
using the visual analog scale (VAS) score as reference.
Convergent validity between 3L, 5L, and VAS was
assessed, using the VAS score as reference. Discrimina-
tory power of both systems is assessed using Shannon’s
indices of informativity. Further comparisons were
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made in terms of feasibility, face validity, and interob-
server and test–retest reliability.
Methods
Participants
A sample of 91 members from an existing panel
(N = 560), who attended at least one previous panel
session, were invited to participate in this study.
Eighty-two participants took part in the study. All
participants were familiar with the protocol and
methods [16]. Participants received a fee of €60—for
full participation (March 2005).
Instruments
The standard EQ-5D descriptive system (3L) was used
in this study next to a ﬁve-level version (5L). For this
study we used a slightly adapted Dutch 5L version
developed in 1993 [17]. This 5L version of EQ-5D is a
prototype developed to support research on the exten-
sion of the EQ-5D descriptive system, and satisﬁed
stated requirements by the EuroQol Group, in particu-
lar the positioning of the two new levels in between
level 1 and 2, and in between level 2 and 3 of the
existing 3L system. It also anticipated an agreed har-
monization of the wording of the most severe level of
the Mobility dimension. At the time of this study, no
ofﬁcial 5L version was advocated by the EuroQol
Group. The grading terms that were used in the level
descriptions on 5L for level 2 (5L-2) were “a little” for
Anxiety/Depression and “mild problems” for the
remaining dimensions. Grading terms for level 4
(5L-4) were “severe” for Pain/Discomfort, “very” for
Anxiety/Depression and “many problems” for the
remaining dimensions. One further alteration was
made to both the 3L and 5L descriptive systems. The
most severe response category in Mobility was
changed from “conﬁned to bed” to “unable to walk
about,” analogous to the extreme response categories
of the other dimensions.
Study Design
Data collection took place in the form of a panel
session and a follow-up postal survey. Participants
attended one of two panel sessions and received a
postal survey 2 weeks later. All participants were
familiar with the vignette presentation method.
In the panel sessions, participants ﬁrst scored their
own health and subsequently valued a set of 10 health
states (acute pharyngitis, exacerbation of eczema,
hip fracture, cerebral vascular accident (CVA)/stroke
with moderate impairments, moderate gastritis, low
spinal cord lesion, mild depression, back and neck
pain, severe dementia, and acute multiple injury). In
the survey participants were asked to score their own
health again (with an added question whether a change
in health took place since the panel session) and ﬁve
additional health states (otitis externa, severe stable
brain injury, irritable bowel syndrome, acute large
burn, and post-traumatic stress disorder).
Our panel of respondents is a panel of laymen, and
therefore the disease vignettes were designed to present
each disease as close to clinical reality as possible
(within the constraints of an A4-sized sheet), including
information on disease duration. The 15 diseases were
presented on a standardized sheet (vignette) which
contains a disease label with a naturalistic description
of the disease; a functional description in terms of
EQ-5D which was left unspeciﬁed for this study; the
course of the disease over a 1-year period; and the
location of the disease with, if relevant, a visual repre-
sentation. Figure 1 shows an example of one of the
vignettes.
Respondents were invited to read the vignettes care-
fully and score the most appropriate level of each
dimension of the EQ-5D descriptive system for all
15-disease vignettes (during the episode), using three
response scales: the common 3L response scale, our 5L
response scale, and a VAS. The VAS consisted of a
horizontal hash-marked line (from 0 to 100) without
corresponding numbers. The VAS scales had the same
descriptive anchors as 3L and 5L for each dimension,
except for the extreme anchors for Pain/Discomfort,
which was “worst imaginable pain or discomfort”
(instead of “extreme”), and for Anxiety/Depression
which was “worst imaginable anxiety or depression”
(instead of “extreme”), to cover the entire possible
continuum of disability, in analogy to the other three
dimensions (ranging from “no problems” to “unable
to”). For consistency with 3L and 5L (increasing
numbers representing increasing severity), we assigned
the value 0 to the anchor “no problems” and the value
100 to the extreme anchor.
The 3L and 5L response scales were presented on
the left-hand and the right-hand side of one page (per
dimension), respectively. The respondents were ﬁrst
asked to score 5L for all dimensions while covering the
right-hand side of the page that showed 3L. Next, they
were asked to cover the left-hand side and score 3L for
all dimensions. Pilot testing revealed that when respon-
dents scored 3L ﬁrst, there was a tendency to not use
the “in-between” levels 2 and 4 of 5L, and for this
reason, all respondents were asked to score 5L ﬁrst.
Adequate instruction was important, stressing the
point that 3L and 5L were two independent ways of
scoring. Subsequently, VAS scores were obtained on a
separate form. This procedure was repeated for each
vignette.
After this design, 255 responses were collected for
each respondent: (15 diseases + own health twice) ¥ 5
dimensions ¥ 3 response scales. At the end of the
survey, respondents were debriefed on feasibility and
face validity of the response scales.
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Analysis
The unit of analysis differed by psychometric property
studied. For the analyses covering redistribution prop-
erties and ordinality, the unit of analysis is the paired
3L-5L response (3L and 5L descriptions of the same
health state by the same respondent). For the analyses
covering convergent validity, discriminatory power
and interobserver and test–retest reliability, the unit of
analysis is the independent 3L, 5L or VAS score.
We used the xL-y notation (e.g., 3L-2) to refer to a
certain level, namely the yth level of the xth system (e.g.,
the second level of the 3L system) and also to the
subgroup of respondents who scored that level of that
system.
Feasibility and face validity. Asking the respondents
the following questions, respectively, tested feasibility
and face validity of the 3L and 5L response scales:
“Which response scale did you ﬁnd easiest to use,” and
“Which response scale do you think best expresses
your opinion?” Respondents were unaware of the
fact that the response scales were being tested for
feasibility.
Redistribution properties of the 3L,5L extension.
Redistribution properties and (in)consistency of re-
sponses were evaluated as follows. The redistribution
diagram (see Fig. 2) shows all potential 3L-5L
response pairs, using arrows. Each arrow (gx.y) repre-
sents a projection of a 3L response (x = 1, 2, 3) on a 5L
response (y = 1, . . . , 5), producing 15 paired 3L-5L
responses. Some arrows are deﬁned as inconsistent,
because apparently the adjacent categories of the 5L
system are skipped.
The consistency box (see Fig. 2) deﬁnes which of
the 15 paired 3L-5L responses are considered (in)
Stroke (CVA, cerebral infarction, cerebral
accident), after the acute phase, is subdivided
into disease stages as follows:
1. mild impairments
2. moderate impairments
3. severe impairments
Value now:
In what state during the disease ?
Location of disease ? When is the disease present ?
january february march april
mo 6 13 20 27 3 10 17 24 3 10 17 24 31 7 14 21 28
tu 7 14 21 28 4 11 18 25 4 11 18 25 1 8 15 22 29
we 1 8 15 22 29 5 12 19 26 5 12 19 26 2 9 16 23 30
th 2 9 16 23 30 6 13 20 27 6 13 20 27 3 10 17 24
fr 3 10 17 24 31 7 14 21 28 7 14 21 28 4 11 18 25
sa 4 11 18 25 1 8 15 22 1 8 15 22 29 5 12 19 26
su 5 12 19 26 2 9 16 23 2 9 16 23 30 6 13 20 27
may june july august
mo 5 12 19 26 2 9 16 23 30 7 14 21 28 4 11 18 25
tu 6 13 20 27 3 10 17 24 1 8 15 22 29 5 12 19 26
we 7 14 21 28 4 11 18 25 2 9 16 23 30 6 13 20 27
th 1 8 15 22 29 5 12 19 26 3 10 17 24 31 7 14 21 28
fr 2 9 16 23 30 6 13 20 27 4 11 18 25 1 8 15 22 29
sa 3 10 17 24 31 7 14 21 28 5 12 19 26 2 9 16 23 30
su 4 11 18 25 1 8 15 22 29 6 13 20 27 3 10 17 24 31
september october november december
mo 1 8 15 22 29 6 13 20 27 3 10 17 24 1 8 15 22 29
tu 2 9 16 23 30 7 14 21 28 4 11 18 25 2 9 16 23 30
we 3 10 17 24 1 8 15 22 29 5 12 19 26 3 10 17 24 31
th 4 11 18 25 2 9 16 23 30 6 13 20 27 4 11 18 25
fr 5 12 19 26 3 10 17 24 31 7 14 21 28 5 12 19 26
sa 6 13 20 27 4 11 18 25 1 8 15 22 29 6 13 20 27
su 7 14 21 28 5 12 19 26 2 9 16 23 30 7 14 21 28
STROKE (CVA)
A patient who experiences moderate
impairments after a stroke throughout the
whole year.
The main symptoms are mild paralyses.
Also disorders like speech inability (aphasia),
slow thought/action, memory problems, problems
with swallowing and incontinence.
Use the response form,
it’s your impression that counts, there are
no right or wrong answers
? Mobility
? Self-Care
? Usual Activities
? Pain/Discomfort
? Anxiety/Depression
Figure 1 Disease vignette with “empty”
EQ-5D descriptive system.
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consistent, as well as the degree of inconsistency, if
present. The subgroups g1.1, g1.2, g2.2, g2.3, g2.4,
g3.4, g3.5 are deﬁned consistent; the remaining sub-
groups are considered inconsistent. The degree of
inconsistency differs by response pair: clearly subgroup
g1.5 is more inconsistent than g1.3. After projecting
the 3L response scale on a 5L response scale (produc-
ing 3L5l responses by recoding 1 = 1, 2 = 3, 3 = 5), the
size of inconsistency was calculated as |3L5l - 5L| - 1.
Sizes of inconsistency are displayed in Figure 2.
The redistribution properties of the consistent
responses were described as proportions of the 3L-5L
response pairs within each 3L response level (3L-1,
3L-2, and 3L-3) and corresponding VAS values, for
each dimension separately. For example, for the ﬁrst
dimension (Mobility), g.1.1 and g1.2 were calculated
as the proportion of respondents that scored 5L-1 and
5L-2 respectively, given that they scored 3L-1. Subse-
quently, the corresponding mean and median VAS
values were calculated for each subgroup of paired
responses. The redistribution proportions may differ
by dimension and 3L response level.
A test of ordinality of 5L. We operationalized ordinal-
ity of the new 5L scale as transitivity between 5L
scores of VAS dependent subgroups. The VAS was used
as norm, assuming it best represented the preference of
the respondent.
Within each dimension, respondents were assigned
to seven hypothetical 5L-subgroups, according to 1)
the individual level score expressed on 3L; and 2) the
individual VAS score (see Fig. 3). Individual 3L-1 and
3L-3 scores were allocated to an upper and lower
subgroup, depending whether their individual VAS
score was respectively above or below the median
3L-group VAS value; the same strategy was applied to
split 3L-2 scores into upper, middle, and lower sub-
groups, depending on the individual VAS score in rela-
tion to the tertile subgroup VAS values, altogether
deﬁning (2 + 2 + 3 =) seven 5L-subgroups.
Subsequently, for each of the seven subgroups,
median and mean 5L level scores were calculated
(treating the ordinal 5L level numbers as cardinal
values in the latter case). Ordinality of 5L was assumed
to be present on the within-group level (within the
three 3L-groups: 3L-1, 3L-2, and 3L-3) if weak tran-
sitivity holds for median 5L scores: for 3L-1 and 3L-3
scores, the hypothesis that lower half upper half
is tested. For 3L-2 scores, the hypotheses lower
tertile  middle tertile  upper tertile are tested. For
5L mean scores, strong transitivity is assumed to hold:
for 3L-1 and 3L-3 scores, lower half <upper half, and
for 3L-2 lower tertile < middle tertile < upper tertile.
3L 5L Level 1 Level 2 Level 3 Level 4 Level 5
Level 1 0 0 1 2 3
Level 2 1 0 0 0 1
Level 3 3 2 1 0 0
The dark cells represent inconsistent responses (size of inconsistency is given in cells)
3L 5L
Consistency box
1
3
g1.1
g1.2
g2.2
g2.3
g2.4
g3.4
g3.5
g1.3
g1.4
g1.5
g2.1
g2.5
g3.1
g3.2
g3.3
1
2
3
4
5
2
Figure 2 Redistribution Diagram: expected relationship between 3L and
5L for one dimension. The seven long arrows (g1.1, g1.2, g2.2, etc.)
represent consistent response pairs and the eight short arrows (g1.3, g1.4,
etc.) inconsistent response pairs.
<p50 lower half
5L values
(median and mean)
VAS subgroups
(median and tertile)
>p50 upper half
<p33 lower tertile
p33–p66 middle tertile
>p33 upper tertile
<p50 lower half
>p50 upper half
within 3L group
comparison
between 3L group
comparison
within 3L group
comparisons
within 3L group
comparison
between 3L group
comparison
3L response
1
2
3 Figure 3 A test of ordinality of 5L. Subgroups
based on 3L response andVAS value.VAS, visual
analog scale.
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Over all ﬁve dimensions, a total of 20 comparisons for
both weak and strong transitivity are made.
On the between-group level (between the three
3L-groups), strong transitivity should hold for 5L
mean scores, with 5L mean boundaries between 3L
and 1 and 3L-2 set at 2, and between 3L and 2 and
3L-3 at 4 (after linear projection). This implies that:
3L-1 upper half < 2 < 3L-2 lower tertile, and 3L-2
upper tertile < 4 < 3L-3 lower half, deﬁning 20 com-
parisons over the ﬁve dimensions in total.
Convergent validity. To determine the extent to which
the three scales measure the same concept, convergent
validity between 3L and VAS, and 5L and VAS was
assessed, using the VAS as reference. The 3L and 5L
level scores were treated as cardinal values so that
means could be used for comparison. For each health
state, 3L, 5L, and VAS means were calculated. Subse-
quently, for each dimension, Spearman rank order coef-
ﬁcients were calculated between 3L and VAS, and 5L
and VAS, respectively. Convergent validity between 3L
and 5L was also assessed on the individual response-
pairs, using Kendall’s tau B statistic and the Gamma
statistic.
Discriminatory power. The Shannon index and the
Shannon Evenness index of informatively were used to
assess discriminatory power. Originating from the ﬁeld
of information theory, the Shannon index has been
widely used in ecologic studies as a measure of biodi-
versity and in molecular biology as a measure of the
information content of DNA molecules [18–20]. In
principle, Shannon’s methodology and indices can be
applied to any classiﬁcation, including health state
classiﬁcation systems such as the EQ-5D, HUI, and
SF-6D [21].
Shannon’s indices are measures of discriminatory
power of any health measurement scale. The basic
characteristic of Shannon’s indices is explained as
follows. In an item where a response option has a very
high (or low) endorsement, e.g., P is more than 0.95
(or less than 0.05), one learns very little because one
can predict with more than 95% certainty what the
answer will be. In other words, that response category
transmits very little information. Conversely, the
maximum amount of information is being transmitted
when, in an item with two response options, P is 0.50
for each response option. This characteristic of an even
distribution underlies the Shannon indices. In case of
an even distribution, the item (dimension) is being
most efﬁciently used, which means that the discrimi-
nant ability of the level descriptors is maximal. The
Shannon indices are purely descriptive measures of the
discriminatory power of a classiﬁcation system, and
have no relation to the content, meaning or clinical
relevance of what the instrument aims to measure.
Informativity was assessed by dimension using the
Shannon index formula:
′ = −
=
∑H p pi i
i
L
log2
1
where H′ represents the absolute amount of informa-
tivity captured, L is the number of possible levels, and
pi is the proportion of the ith level in the sample. The
higher the outcome of the index, the more information
is captured by the system. In case of an even (or rect-
angular) distribution, i.e., if all levels are evenly ﬁlled,
the optimal amount of information is captured and the
Shannon index has reached its upper limit (H′max)
which is represented by the following formula:
H′max = log2 L, which amounts to 1.58 in 3L, and
2.32 in 5L. If the number of levels is increased, H′max
increases accordingly. Nevertheless, the empirical
informativity H′ will only increase if the newly added
categories are actually used. The Shannon index com-
bines the number of categories deﬁned by a system as
measure with the extent in which the information is
(empirically) evenly spread over the categories. The
Shannon Evenness index exclusively reﬂects the Even-
ness (rectangularity) of a distribution, regardless of the
number of levels. The Shannon Evenness measure
J′ = H′/H′max expresses the use of the system (H′)
given its potential (H’max). Shannon’s index H′ can be
considered an expression of the absolute informativity
of a system, whereas Shannon’s Evenness index J′
expresses the relative informativity of a system.
Reliability: interobserver and test–
retest. Interobserver reliability was estimated by
dimension for 3L and 5L over the 15 health states,
using intraclass correlation coefﬁcients (ICCs) (two-
way random effects model, single measures, absolute
agreement). Test–retest reliability was estimated by the
same type of ICC on the respondents’ own health
rating, for each dimension separately, and for each of
the three response scales.
Results
Participants
The mean age of the participants was 53.6 years, with
42.7% being males. Of the 82 respondents who
attended in the panel sessions, 81 returned the survey.
Feasibility and Face Validity
Feasibility of the three response scales was evaluated
by 78 persons of whom 59 (76%) responded that 5L
was easiest to use, nine (12%) responded that the VAS
was easiest, and seven (9%) that 3L was easiest to use.
Three respondents (4%) were of opinion that there
was no difference. Of the 80 respondents who
answered the question on face validity of the three
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response scales, 60 (75%) responded that 5L best
expressed their opinion, while 14 (18%) selected the
VAS, and ﬁve (6%) responded that 3L expressed their
opinion best. One respondent (1%) was indifferent.
Redistribution Properties from 3L to 5L
Table 1 shows the proportion of inconsistent responses
and the average size of inconsistency for each dimen-
sion. The number of inconsistencies is highest in Pain/
Discomfort (n = 19) and lowest in Mobility (n = 6).
The average proportion of inconsistencies by dimen-
sion is 1.1%.
Table 2 gives the mean and median VAS values for
each of the 3L-5L response pairs as deﬁned by
Figure 2. All mean and median VAS scores show
increasing values when going from the healthiest sub-
group (g1.1) to the most disabled subgroup (g3.5),
regardless of dimension. Proportions show consider-
able variation across dimensions. For the 3L-1 sub-
groups of each dimension, there is always a higher
proportion in 5L-1 (g1.1) compared with 5L-2 (g1.2).
The most skewed relative frequency distribution is
in Mobility (91/9) and the least in Usual Activities
(58/42). The three 3L-2 subgroups showed variable
Table 1 Redistribution properties from 3L to 5L: inconsistent responses*
Dimension Observations Inconsistencies (%)
Average size
of inconsistency
Mobility 1182 6 (0.5) 1.33
Self-Care 1190 16 (1.3) 1.56
Usual Activities 1195 17 (1.4) 1.53
Pain/Discomfort 1164 19 (1.6) 1.37
Anxiety/Depression 1181 7 (0.6) 1.43
Total 5912 65 (1.1) 1.46
*Consistent and inconsistent responses and size of inconsistency are deﬁned according to Figure 2.
Table 2 Redistribution properties from 3L to 5L: consistent responses
Dimension 3L 5L Subgroup* n Proportions (%) VAS mean† VAS median
Mobility 1 1 g1.1 543 91 1.3 0
2 g1.2 56 9 5.8 5
2 2 g2.2 91 23 21.2 15
3 g2.3 157 39 36.0 31
4 g2.4 152 38 63.8 72
3 4 g3.4 65 37 83.9 88
5 g3.5 112 63 97.4 100
Self-Care 1 1 g1.1 391 82 1.8 0
2 g1.2 85 18 8.1 7
2 2 g2.2 118 28 15.3 11
3 g2.3 180 42 36.0 33
4 g2.4 131 31 65.3 70
3 4 g3.4 124 46 77.9 85
5 g3.5 145 54 92.1 100
Usual Activities 1 1 g1.1 133 58 2.5 0
2 g1.2 98 42 6.5 5
2 2 g2.2 166 29 14.2 12
3 g2.3 224 39 32.3 30
4 g2.4 187 32 61.9 65
3 4 g3.4 161 44 79.1 85
5 g3.5 209 56 96.2 100
Pain/Discomfort 1 1 g1.1 139 59 7.4 0
2 g1.2 98 41 16.9 10
2 2 g2.2 175 27 17.4 12
3 g2.3 359 56 36.6 34
4 g2.4 104 16 63.9 72
3 4 g3.4 155 57 77.2 83
5 g3.5 115 43 92.8 98
Anxiety/Depression 1 1 g1.1 301 70 4.1 0
2 g1.2 130 30 11.3 9
2 2 g2.2 111 23 22.5 16
3 g2.3 269 57 42.0 41
4 g2.4 95 20 67.1 71
3 4 g3.4 152 57 79.1 84
5 g3.5 116 43 92.3 97
*Subgroups are deﬁned according to Figure 2.
†VAS scores are recoded into the value 100 for worst health state and 0 for best health state.
VAS, visual analog scale.
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proportions per dimension; the most evenly spread
proportions were found in Usual Activities (29/39/32),
the most unevenly spread in Pain/Discomfort (27/56/
16). The 3L-3 scores corresponded with the largest
proportion in 5L-4 in case of the dimensions Pain/
Discomfort and Anxiety/Depression, but were associ-
ated with 5L-5 scores for the remaining dimensions.
A test of ordinality of 5L. The results for the ordinal-
ity test are shown in Table 3. Taking one 3L group,
Usual Activities 3L-2, as an example, we see that 582
respondents fell in this group, and tertile VAS scores
(18 and 48) deﬁne three subgroups, a lower tertile
subgroup (n = 195, VAS range 0–18), middle tertile
subgroup (n = 197, VAS range 19–48), and an upper
tertile subgroup (n = 190, VAS range 49–100). Subse-
quently, for each of the three subgroups, 5L medians
and means were calculated, ranging respectively from
2 to 4 and from 2.38 to 3.73.
As all 5L median subgroup values show increasing
or equal values on all dimensions, on the 3L within-
group level, weak transitivity holds for all 20 compari-
sons. Strong transitivity holds for all 20 comparisons
on mean 5L scores because all means within the three
3L groups are in ascending order on all dimensions,
when going from lower half 3L-1 to upper half 3L-3.
On the 3L between-group level strong transitivity
holds for all 20 comparisons on mean 5L scores,
because 5L mean upper half 3L-1 scores are always <2,
lower tertile 3L-2 scores >2, upper tertile scores <4,
and lower half 3L-3 scores >4.
Convergent validity. Table 4 shows the health state
values for the three response scales (3L, 5L, and VAS)
by dimension. The Spearman rank coefﬁcients between
3L and VAS ranged from 0.88 (Pain/Discomfort) to
0.99 (Mobility and Usual Activities), and between 5L
and VAS from 0.90 (Pain/Discomfort) to 0.99 (Mobil-
ity and Usual Activities). Spearman rank correlation
coefﬁcients between 3L and 5L (not shown in Table 4)
were 0.97 for Pain/Discomfort and 0.99 for the
remaining dimensions, conveying strong convergence.
Table 3 Ordinality of the 5L descriptive system. Median and mean 5L level scores of VAS dependent subgroups*
Dimension 3L
VAS dependent
subgroups (VAS range) Observations 5L median 5L mean†
Mobility 1 Lower half (0) 415 1 1.01
Upper half (1–54) 184 1 1.28
2 Lower tertile (0–23) 137 2 2.54
Middle tertile (24–53) 132 3 3.17
Upper tertile (54–100) 134 4 3.72
3 Lower half (0–99) 94 4 4.29
Upper half (100) 86 5 4.93
Self-Care 1 Lower half (0) 298 1 1.05
Upper half (1–86) 184 1 1.47
2 Lower tertile (0–21) 149 2 2.39
Middle tertile (22–51) 142 3 3.03
Upper tertile (52–100) 144 4 3.64
3 Lower half (0–95) 143 4 4.22
Upper half (96–100) 130 5 4.81
Usual Activities 1 Lower half (0–1) 117 1 1.11
Upper half (2–74) 118 2 1.81
2 Lower tertile (0–18) 195 2 2.38
Middle tertile (19–48) 197 3 3.03
Upper tertile (49–100) 190 4 3.73
3 Lower half (10–95) 195 4 4.17
Upper half (96–100) 183 5 4.88
Pain/Discomfort 1 Lower half (0–3) 122 1 1.20
Upper half (4–100) 124 2 1.77
2 Lower tertile (0–21) 212 2 2.41
Middle tertile (22–44) 213 3 2.91
Upper tertile (45–100) 218 3 3.29
3 Lower half (0–89) 139 4 4.06
Upper half (90–100) 136 5 4.72
Anxiety/Depression 1 Lower half (0–1) 224 1 1.04
Upper half (2–100) 209 2 1.60
2 Lower tertile (0–29) 161 2 2.50
Middle tertile (30–50) 158 3 2.97
Upper tertile (51–99) 159 3 3.40
3 Lower half (0–90) 143 4 4.18
Upper half (91–100) 127 5 4.68
*The VAS dependent subgroups are deﬁned according to Figure 3.
†Level rank score treated as cardinal value.
VAS, visual analog scale.
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Convergent validity between the paired 3L-5L
responses was estimated as follows: Kendall’s tau B
was 0.82 average across dimensions, ranging from
0.77 (Pain/Discomfort) to 0.88 (Mobility) and Gamma
was 0.98 on average, ranging from 0.97 (Pain/
Discomfort) to 1.00 (Mobility).
Discriminatory power. Table 5 shows the informativ-
ity results of 3L and 5L. In terms of absolute informa-
tivity (Shannon’s H′), 5L consistently shows higher
results with an average difference of 0.68. Relative
informativity in terms of Shannon’s Evenness (J′) is
high in general and shows similar results between 3L
and 5L.
Reliability: interobserver and test–
retest. Interobserver reliability varies between 3L and
5L, and between dimensions (Table 6). ICCs for 3L
range from 0.33 to 0.65 (average 0.49), and for 5L
from 0.22 to 0.83 (average 0.57). Finally, results for
test–retest reliability (Table 6) show average ICCs are
highest in 5L (0.69), followed by 3L (0.52) and VAS
(0.51). The time interval between test and retest was
3 weeks on average.
Discussion
The aim of this study was to compare the performance
of the standard 3L EQ-5D with a 5L version in terms
Table 4 Convergent validity. 3L, 5L, and VAS mean values* by
dimension with Spearman rank order coefﬁcients for 3L-VAS
and 5L-VAS, all diseases ranked by VAS for each dimension
separately
VAS 3L 5L
Mobility
ACPH Pharyngitis (acute) 0.38 1.00 1.03
OTXT Otitis externa 1.24 1.02 1.02
EXEC Eczema (exacerbation) 1.76 1.05 1.13
DEPM Depression (mild) 2.26 1.01 1.03
PTSS Post-traumatic stress disease 4.04 1.06 1.18
GASM Gastritis (moderate) 4.63 1.19 1.25
IRBS Irritable bowel syndrome 6.86 1.19 1.42
DMNS Dementia (severe) 21.13 1.54 2.04
BACK Back/neck pain 21.77 1.76 2.27
CVAM CVA/stroke (moderate) 43.32 2.01 3.04
BINS Brain injury (severe, stable) 46.15 2.05 3.22
BURN Burn (acute, large) 56.00 2.15 3.44
HIPF Hip fracture 63.91 2.28 3.92
MINA Multiple injury (acute) 72.39 2.41 3.97
SPIN Spinal cord lesion (low) 97.71 2.99 4.96
Spearman 0.99† 0.99†
Self-Care
ACPH 1.82 1.01 1.05
OTXT 2.34 1.10 1.15
EXEC 5.56 1.27 1.55
IRBS 5.66 1.13 1.31
GASM 7.41 1.19 1.37
PTSS 13.79 1.40 1.76
DEPM 16.86 1.61 2.00
BACK 18.18 1.57 2.01
HIPF 46.39 2.22 3.49
BINS 50.85 2.15 3.30
CVAM 53.14 2.25 3.58
BURN 66.93 2.44 3.86
SPIN 77.51 2.64 4.31
MINA 78.82 2.67 4.14
DMNS 82.73 2.71 4.41
Spearman 0.98† 0.98†
Usual Activities
ACPH 4.03 1.25 1.58
OTXT 10.81 1.38 1.85
EXEC 13.27 1.71 2.30
IRBS 16.54 1.58 2.08
GASM 18.82 1.71 2.20
BACK 28.16 1.89 2.71
DEPM 33.34 1.96 2.92
PTSS 39.35 2.03 3.03
HIPF 61.34 2.38 3.85
CVAM 66.34 2.49 3.88
BINS 71.33 2.53 4.00
BURN 78.60 2.64 4.28
MINA 82.98 2.68 4.24
SPIN 85.94 2.73 4.36
DMNS 87.66 2.84 4.61
Spearman 0.99† 0.99†
Pain/Discomfort
ACPH 16.28 1.73 2.33
PTSS 17.15 1.47 1.91
DEPM 22.92 1.45 2.30
EXEC 22.99 1.78 2.56
GASM 25.36 1.88 2.44
IRBS 31.43 1.85 2.66
BACK 38.52 2.09 3.00
OTXT 40.03 2.09 3.13
DMNS 43.18 1.78 2.46
CVAM 45.58 1.97 2.92
SPIN 52.44 2.06 2.99
HIPF 53.86 2.31 3.51
BINS 61.81 2.42 3.66
MINA 75.64 2.69 4.14
BURN 83.59 2.78 4.43
Spearman 0.88† 0.90†
Table 4 continued
VAS 3L 5L
Anxiety/Depression
ACPH 3.17 1.12 1.27
OTXT 4.76 1.13 1.33
IRBS 10.98 1.23 1.60
GASM 11.78 1.27 1.63
EXEC 13.68 1.36 1.81
BACK 23.90 1.58 2.12
HIPF 26.03 1.62 2.15
DEPM 45.29 2.10 3.10
CVAM 51.73 2.24 3.32
BINS 57.84 2.34 3.60
DMNS 63.65 2.31 3.52
PTSS 65.01 2.42 3.75
MINA 66.09 2.28 3.49
SPIN 66.42 2.46 3.71
BURN 72.61 2.46 3.90
Spearman 0.98† 0.97†
*3L and 5L rank level scores treated as cardinal values.
†Correlation is signiﬁcant at the 0.01 level.
VAS, visual analog scale.
Table 5 Shannon’s index (H′) and Shannon’s Evenness index
( J′) values for 3L and 5L
3L 5L
H′ J′ H′ J′
Mobility 1.44 0.91 2.05 0.88
Self-Care 1.55 0.98 2.23 0.96
Usual Activities 1.49 0.94 2.26 0.97
Pain/Discomfort 1.44 0.91 2.21 0.95
Anxiety/Depression 1.55 0.98 2.26 0.97
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of feasibility, face validity, redistribution properties,
ordinality, convergent validity, discriminatory power,
and interobserver and test–retest reliability.
Feasibility of 5L was very high, which is in accor-
dance with results found elsewhere. Preston et al.
investigated feasibility for 11 different rating formats
(ranging from 2 to 11 and a 101-point scale), and
found that feasibility peaked at ﬁve levels, although
preferences were not that strong as our results indicate
[22]. Surprisingly, the question on face validity
revealed that 75% of the respondents were of opinion
that 5L expressed best their opinion, disregarding both
the VAS as the most reﬁned response scale and 3L as
most condensed format. As found elsewhere, this con-
ﬁrms the notion that the precision of the VAS might be
illusory as respondents mentally divide the VAS con-
tinuum in a smaller number of segments [22,23]. These
results, which strongly favor the new 5L system, were
also supported by the results on informativity. Extend-
ing the EQ-5D descriptive system to 5L produced
higher informativity than 3L in all dimensions, as
expected. Surprisingly, Evenness did not deteriorate in
5L but was similar to 3L. The high Evenness score in
all 5L dimensions indicates that the extra levels are
indeed used very efﬁciently.
The proportion of inconsistent responses was very
low (average 1.1%) which indicates that respondents
were able to consistently use the 3L and 5L systems.
Validation of the 5L extension is strongly supported by
the redistribution results, which consistently show
increasing VAS means and medians per dimension
(Table 2). The frequency proportions, however,
showed varying distributions over the dimensions. As
expected, the g1.1 subgroup always shows the largest
proportion, because some health states obviously
display no symptoms or problems on a particular
dimension no matter how reﬁned the response scale.
Nevertheless, in Usual Activities, Pain/Discomfort, and
Anxiety/Depression, the g1.2 proportion was large
(42%, 41%, and 30%, respectively) which strongly
supports the positioning of an extra (second) level for
those dimensions. In all dimensions, the g3.4 propor-
tion was large, which seems to support the inclusion of
a fourth level in this position, because many respon-
dents indicate that they valued this particular disease
less extreme than 3L-3 describes. The same applies to
g2.2 and g2.4. As expected, the most severe subgroup
(g3.5) deviates most from the extreme VAS anchor in
Pain/Discomfort and Anxiety/Depression, because
3L-3 and 5L-5 level descriptions (extreme pain;
extremely anxious) are less severe than the extreme
VAS anchors (worst imaginable pain, worst imaginable
anxiety/depression). Self-Care g3.5 is an exception
where there is a deviation of an average of eight VAS
units from the identical VAS anchors.
Ordinality of 5L was achieved in all cases, which
again is in support of the validity of the extended 5L
system. Convergent validity between 3L and VAS, and
5L and VAS were very high and showed highly similar
results (Table 4).
Regarding reliability, the 5L version generally
showed better interobserver reliability and test–retest
reliability than 3L. Surprisingly we found considerable
variation in reliability across dimensions. Interob-
server reliability is particularly low in Pain/Discomfort
and Anxiety/Depression domains. One explanation
may be that these dimensions are nonphysical, more
subjective, by nature. Another possibility is that these
dimensions are hybrids of pain and discomfort, and of
anxiety and depression, respectively. When scoring
disease vignettes, some respondents might systemati-
cally put more weight on, e.g., discomfort while others
focus on pain. The high test–retest reliability (on self-
reported health) seems to support these explanations.
Test–retest reliability was rather low for the self-care
domain for both 3L and 5L. Because almost all respon-
dents reported no problems (especially on 3L), there is
hardly variability between respondents, and ICCs,
relying on variance, generally underestimate agree-
ment when this is the case.
Two potential weaknesses of the current study need
to be addressed. First, regarding the testing procedure,
3L and 5L were presented on one sheet and panellists
were asked to score 5L dimensions ﬁrst while covering
3L and vice versa. We cannot be sure that raters
actually complied to the blinding procedure in the
follow-up measurement. This may have strengthened
associations obtained at the second measurement.
Also, there might have been an order effect.
Second, we had respondents scoring the EQ-5D for
the health of a hypothetical patient represented by a
vignette, instead of scoring their own self-reported
health. The results might be different when our 5L
version would be tested as a self-report instrument in
patient population settings.
We only compared the standard EQ-5D3Lwith a 5L
system, whereas six or seven levels might even outper-
form 5L, or four levels might sufﬁciently increase
performance over 3L. Nevertheless, 5L appears to be
an optimal number of response options concerning
Table 6 Interobserver reliability (ICCs) for 3L and 5L, all health
states (n = 1230), and test–retest reliability for respondents’ own
health on 3L, 5L, and VAS (n = 68)
Dimension
Interobserver reliability Test–retest reliability
3L 5L 3L 5L VAS
Mobility 0.65 0.83 0.85 0.84 0.53
Self-Care 0.59 0.76 -0.02 0.43 0.46
Usual Activities 0.37 0.61 0.56 0.73 0.49
Pain/Discomfort 0.33 0.22 0.59 0.81 0.69
Anxiety/Depression 0.49 0.44 0.60 0.65 0.39
Average ICC* 0.49 0.57 0.52 0.69 0.51
*All ICCs were two-way random, absolute agreement, single measures.
ICC, intraclass correlation coefﬁcient;VAS, visual analog scale.
Comparing the EQ-5D with a Five-Level Version 283
reliability [24,25]. Because of the lower threshold (level
5L-2), we expect a less severe ceiling effect in the 5L
version, and increased beneﬁt in the detection of mild
problems and in measuring and monitoring general
population health. Awaiting a valuation study for 5L, a
set of preference weights was developed for our 5L
version of EQ-5D, using methodology based on item
response theory [26]. So far, the 5L descriptive system
presented here seems to be a valid, reliable, and useful
improvement over the standard 3L system.
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